Kristin Leigh Moffitt, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pneumococcal Vaccines | 8 | 2020 | 390 | 2.430 |
Why?
|
Pneumococcal Infections | 8 | 2020 | 499 | 2.240 |
Why?
|
Streptococcus pneumoniae | 7 | 2020 | 719 | 1.320 |
Why?
|
Th17 Cells | 4 | 2018 | 768 | 1.040 |
Why?
|
Pneumonia, Staphylococcal | 2 | 2022 | 40 | 0.990 |
Why?
|
Staphylococcal Infections | 2 | 2022 | 1395 | 0.840 |
Why?
|
Toll-Like Receptor 2 | 2 | 2015 | 348 | 0.830 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 3 | 2022 | 685 | 0.750 |
Why?
|
Soft Tissue Infections | 1 | 2021 | 161 | 0.660 |
Why?
|
Abscess | 1 | 2021 | 601 | 0.580 |
Why?
|
Influenza, Human | 3 | 2023 | 1503 | 0.550 |
Why?
|
Staphylococcus aureus | 2 | 2022 | 1450 | 0.540 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2021 | 1113 | 0.490 |
Why?
|
Carrier State | 2 | 2015 | 520 | 0.480 |
Why?
|
Vaccines, Conjugate | 1 | 2016 | 322 | 0.470 |
Why?
|
STAT3 Transcription Factor | 1 | 2018 | 870 | 0.460 |
Why?
|
Antigens, Bacterial | 2 | 2016 | 1152 | 0.420 |
Why?
|
Bacterial Vaccines | 1 | 2014 | 397 | 0.390 |
Why?
|
Pneumonia, Pneumococcal | 2 | 2020 | 127 | 0.390 |
Why?
|
Lipoproteins | 1 | 2015 | 882 | 0.350 |
Why?
|
Cross Reactions | 2 | 2024 | 813 | 0.300 |
Why?
|
Antibodies, Bacterial | 1 | 2012 | 1442 | 0.270 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9320 | 0.250 |
Why?
|
Sorting Nexins | 1 | 2024 | 26 | 0.240 |
Why?
|
Interleukin-17 | 3 | 2017 | 894 | 0.230 |
Why?
|
Molecular Mimicry | 1 | 2024 | 199 | 0.220 |
Why?
|
Lipids | 1 | 2014 | 3290 | 0.210 |
Why?
|
Methicillin | 1 | 2022 | 62 | 0.210 |
Why?
|
Chemotactic Factors | 1 | 2022 | 191 | 0.200 |
Why?
|
Systemic Inflammatory Response Syndrome | 2 | 2024 | 613 | 0.200 |
Why?
|
Quality of Life | 1 | 2022 | 12977 | 0.190 |
Why?
|
Multilocus Sequence Typing | 1 | 2021 | 99 | 0.190 |
Why?
|
Bacterial Proteins | 1 | 2014 | 3788 | 0.180 |
Why?
|
Autoantibodies | 3 | 2024 | 2044 | 0.180 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2012 | 4297 | 0.170 |
Why?
|
Haploinsufficiency | 2 | 2022 | 322 | 0.160 |
Why?
|
Interferon Type I | 1 | 2022 | 545 | 0.160 |
Why?
|
Vaccines, Inactivated | 2 | 2017 | 180 | 0.160 |
Why?
|
Membrane Proteins | 1 | 2015 | 7786 | 0.150 |
Why?
|
Epitopes | 1 | 2024 | 2505 | 0.150 |
Why?
|
Adjuvants, Immunologic | 2 | 2012 | 1028 | 0.140 |
Why?
|
Nasopharynx | 2 | 2017 | 389 | 0.130 |
Why?
|
GATA2 Transcription Factor | 1 | 2016 | 157 | 0.130 |
Why?
|
Mice | 8 | 2021 | 80251 | 0.130 |
Why?
|
Vancomycin | 1 | 2019 | 495 | 0.130 |
Why?
|
Computational Biology | 2 | 2021 | 3489 | 0.120 |
Why?
|
Complement C3 | 1 | 2017 | 456 | 0.120 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 222 | 0.120 |
Why?
|
Interferon-gamma | 1 | 2022 | 3143 | 0.110 |
Why?
|
Mice, Inbred C57BL | 5 | 2020 | 21600 | 0.110 |
Why?
|
Immunization Programs | 1 | 2016 | 261 | 0.110 |
Why?
|
Immunization | 2 | 2020 | 1220 | 0.110 |
Why?
|
Animals | 10 | 2021 | 166558 | 0.110 |
Why?
|
Pain Measurement | 1 | 2022 | 3442 | 0.100 |
Why?
|
Aluminum Hydroxide | 1 | 2012 | 55 | 0.100 |
Why?
|
Child | 8 | 2024 | 78492 | 0.100 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 1 | 2012 | 160 | 0.100 |
Why?
|
RNA, Messenger | 1 | 2022 | 12767 | 0.070 |
Why?
|
Disease Models, Animal | 3 | 2018 | 17869 | 0.070 |
Why?
|
Spleen | 1 | 2012 | 2272 | 0.070 |
Why?
|
Immunity, Cellular | 1 | 2012 | 1550 | 0.070 |
Why?
|
Adaptive Immunity | 1 | 2011 | 722 | 0.070 |
Why?
|
Critical Illness | 1 | 2019 | 2693 | 0.070 |
Why?
|
Rabbits | 1 | 2012 | 4788 | 0.070 |
Why?
|
Mass Spectrometry | 1 | 2012 | 2176 | 0.060 |
Why?
|
Vaccination | 1 | 2016 | 3283 | 0.060 |
Why?
|
Immunity, Innate | 1 | 2016 | 3025 | 0.060 |
Why?
|
Case-Control Studies | 1 | 2021 | 21693 | 0.050 |
Why?
|
NF-kappa B p52 Subunit | 1 | 2022 | 34 | 0.050 |
Why?
|
Humans | 12 | 2024 | 746630 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2021 | 19819 | 0.050 |
Why?
|
Mice, Knockout | 2 | 2015 | 14253 | 0.050 |
Why?
|
Antibodies, Viral | 2 | 2024 | 3074 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7229 | 0.050 |
Why?
|
Immunoglobulin G | 1 | 2012 | 4481 | 0.040 |
Why?
|
Neutralization Tests | 1 | 2022 | 731 | 0.040 |
Why?
|
Escherichia coli | 1 | 2012 | 4168 | 0.040 |
Why?
|
Biomass | 1 | 2020 | 131 | 0.040 |
Why?
|
Macrophages | 1 | 2014 | 5664 | 0.040 |
Why?
|
Bioreactors | 1 | 2020 | 241 | 0.040 |
Why?
|
Viral Envelope Proteins | 1 | 2022 | 623 | 0.040 |
Why?
|
B-Lymphocytes | 1 | 2012 | 4673 | 0.040 |
Why?
|
Opsonin Proteins | 1 | 2017 | 146 | 0.040 |
Why?
|
Binding Sites, Antibody | 1 | 2017 | 337 | 0.030 |
Why?
|
Female | 6 | 2024 | 382450 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1824 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2024 | 2405 | 0.030 |
Why?
|
Male | 4 | 2024 | 351420 | 0.030 |
Why?
|
Child, Preschool | 3 | 2024 | 41390 | 0.030 |
Why?
|
NF-kappa B | 1 | 2022 | 2464 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2017 | 5843 | 0.030 |
Why?
|
Adolescent | 4 | 2024 | 86278 | 0.030 |
Why?
|
Respiration, Artificial | 1 | 2023 | 2573 | 0.020 |
Why?
|
Equipment Design | 1 | 2020 | 3510 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2022 | 3659 | 0.020 |
Why?
|
Phagocytosis | 1 | 2017 | 1524 | 0.020 |
Why?
|
Mutation | 1 | 2014 | 29627 | 0.020 |
Why?
|
Cell Count | 1 | 2012 | 1833 | 0.020 |
Why?
|
Autoantigens | 1 | 2012 | 870 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2468 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2024 | 10018 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10138 | 0.020 |
Why?
|
Hospitalization | 1 | 2023 | 10333 | 0.010 |
Why?
|
Sepsis | 1 | 2017 | 2590 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12728 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2019 | 25759 | 0.010 |
Why?
|
Infant | 1 | 2019 | 35456 | 0.010 |
Why?
|
Prospective Studies | 1 | 2019 | 53253 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 78313 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 63732 | 0.010 |
Why?
|
Adult | 1 | 2022 | 215192 | 0.000 |
Why?
|